Referencias:
- Estler, (1979) Arch. Int. Pharmacodyn. Ther., 239, pp. 326-330
- Berkowitz, Tarver, Spector, (1970) Eur. J. Pharmacol., 10, pp. 64-71
- Cardinali, (1978) Eur. J. Pharmacol., 47, pp. 239-243
- Cardinali, (1977) Neuropharmacology, 16, pp. 785-790
- Greengard, (1979) Fed. Proc. Fed. Am. Soc. Exp. Biol., 38, pp. 2208-2217
- Weiss, Hall, (1977) Annu. Rev. Pharmacol. Toxicol., 17, pp. 441-477
- Sattin, Rall, (1970) Mol. Pharmacol., 6, pp. 13-23
- Scholfield, (1978) Br. J. Pharmacol., 63, pp. 239-244
- Butt, Celler, Cuthbert, Francis, Saeed, (1979) Eur. J. Pharmacol., 53, pp. 375-378
- Jhamandas, Sawvnok, Sutak, (1978) Eur. J. Pharmacol., 49, pp. 309-312
Citas:
---------- APA ----------
(1980)
. Methylxanthines: possible mechanisms of action in brain. Trends in Pharmacological Sciences, 1(2), 405-407.
http://dx.doi.org/10.1016/0165-6147(80)90064-4---------- CHICAGO ----------
Cardinali, D.P.
"Methylxanthines: possible mechanisms of action in brain"
. Trends in Pharmacological Sciences 1, no. 2
(1980) : 405-407.
http://dx.doi.org/10.1016/0165-6147(80)90064-4---------- MLA ----------
Cardinali, D.P.
"Methylxanthines: possible mechanisms of action in brain"
. Trends in Pharmacological Sciences, vol. 1, no. 2, 1980, pp. 405-407.
http://dx.doi.org/10.1016/0165-6147(80)90064-4---------- VANCOUVER ----------
Cardinali, D.P. Methylxanthines: possible mechanisms of action in brain. Trends Pharmacol. Sci. 1980;1(2):405-407.
http://dx.doi.org/10.1016/0165-6147(80)90064-4